Clinical Trials Logo
  1. Home
  2. Pain, Intractable
  3. NCT04572776

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Pain, Intractable Clinical Trial

Official title:
A Multicenter, Randomized, 2-Arm, Phase 3 Study to Assess the Efficacy and Safety of a Single Epidural Administration of Resiniferatoxin Versus Standard of Care (SoC) for the Treatment of Intractable Pain Associated With Cancer

Clinical Trial Summary

This is a Phase 3 study to assess the safety and efficacy of a single epidural administration of Resiniferatoxin versus standard of care for the treatment of intractable pain associated with cancer.

Clinical Trial Description

This study is a multicenter, randomized Phase 3 study to assess the safety and efficacy of a single epidural administration of Resiniferatoxin versus standard of care (SOC) for the treatment of intractable pain associated with cancer. Subjects will be followed for 12 weeks after treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04572776
Study type Interventional
Source Sorrento Therapeutics, Inc.
Contact
Status Withdrawn
Phase Phase 3
Start date December 2020
Completion date March 2023
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03887494 - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) N/A
Recruiting NCT05761392 - APP-based Precise Management System of Chronic Intractable Pain N/A
Suspended NCT05067257 - Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer Phase 2
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Withdrawn NCT01951911 - Effectiveness of Ketamine in Malignant Neuropathic Pain Relief Phase 3
Completed NCT04701008 - Efficacy of Ketamine in Post Anesthesia Recovery Room
Completed NCT03350256 - BurstDR™ micrOdosing stimuLation in De-novo Patients N/A
Completed NCT04602286 - How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) N/A
Completed NCT04625504 - Investigating Biological Targets, Markers, and Intervention for Chronic Pain N/A
Recruiting NCT05398003 - Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M) N/A
Completed NCT02886286 - Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain Phase 4
Completed NCT00216684 - Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics Phase 3
Recruiting NCT05775510 - Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain
Active, not recruiting NCT04727216 - Intermittent vs. Continuous Dorsal Root Ganglion Stimulation N/A
Completed NCT02091076 - Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing Phase 1/Phase 2
Completed NCT01166906 - Pain Blocking During Drug Administration or Blood Collection With Needles
Recruiting NCT04876469 - Radiocontrast Media in the Pulsed Radiofrequency Treatment N/A
Completed NCT05108103 - Determination of Longus Colli Muscle Thickness by Ultrasonography
Completed NCT04727749 - Pawsitive Impacts of Therapy Dog Visits N/A
Completed NCT04096391 - Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population N/A